Showing results (1251-1260 of 1,307) with videos related to

Sort By:
Pageof 131
The Lancet. Neurology|February 19, 2022
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation studyPascal Benkert, Stephanie Meier, Sabine Schaedelin, et al.
Trials|September 11, 2024
MultiSCRIPT-Cycle 1-a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trialPerrine Janiaud, Chiara Zecca, Anke Salmen, et al.
Journal of Medicinal Chemistry|July 14, 2000
In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasiaJ C Barrow, P G Nantermet, H G Selnick, et al.
BMC Cancer|December 5, 2023
Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative studyAlice Guan, Eduardo J Santiago-Rodríguez, Benjamin I Chung, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 14, 2024
Complement Activation Is Associated With Disease Severity in Multiple SclerosisJohanna Oechtering, Kerstin Stein, Sabine A Schaedelin, et al.
Acta Diabetologica|October 27, 2009
Variation in the checkpoint kinase 2 gene is associated with type 2 diabetes in multiple populationsKari E North, Nora Franceschini, Christy L Avery, et al.
Upsala Journal of Medical Sciences|January 9, 2019
Rationale for a Swedish cohort consortiumJohan Sundström, Cecilia Björkelund, Vilmantas Giedraitis, et al.
Nature|December 14, 2022
Recurrent repeat expansions in human cancer genomesGraham S Erwin, Gamze Gürsoy, Rashid Al-Abri, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 28, 2025
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS CohortGiulio Disanto, Sabine Schaedelin, Johanna Oechtering, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2006
Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease familiesLianna Ishihara, Rachel A Gibson, Liling Warren, et al.
Pageof 131